Increased expression of KIAA1199 has been reported in a number of clinical conditions e.g. in patients with different cancer types12,14,16,17 and in patients with rheumatoid arthritis and osteoarthritis, both conditions are characterized by joint inflammation21–24. Here, CEMIP is linked to rheumatoid arthritis.